Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 4Myeloproliferative Disorders 3Myelodysplastic Syndromes 2Sarcoma, Kaposi 1Leukemia, Myelomonocytic, Chronic 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Zidovudine 9Interferon alpha-2 5Doxorubicin 5Vincristine 4Bleomycin 4pomalidomide 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3sargramostim 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Didanosine 2Biopsy 2Bevacizumab 2tocilizumab 1pembrolizumab 1halofuginone 1entinostat 1cabozantinib 1abemaciclib 1Zalcitabine 1Valganciclovir 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Kaposi × Liposomes × Clear all
NCT00001059 2012-04-17

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
120 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡